TW-1 (New York University Grossman School of Medicine/East China Normal University)

N/A

Report date: 2025/01/26 16:06:12

Base Information

Drug NameTW-1 (New York University Grossman School of Medicine/East China Normal University)
Drug Alias Nameanti-PrP mAb (New York University Grossman School of Medicine/East China Normal University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMajor prion protein inhibitorsMicrotubule-associated protein tau inhibitors
TargetsMajor prion proteinMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEast China Normal University
China Registration ClassN/A

Develop Information

Active CompaniesNew York University School Of MedicineEast China Normal University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A